Invention Grant
- Patent Title: Uses of dual NK1/NK3 receptor antagonists for treating sex-hormone diseases
-
Application No.: US15157430Application Date: 2016-05-18
-
Publication No.: US10195205B2Publication Date: 2019-02-05
- Inventor: Mike Trower
- Applicant: NeRRe Therapeutics Limited
- Applicant Address: GB Stevenage, Herts
- Assignee: NeRRe Therapeutics Limited
- Current Assignee: NeRRe Therapeutics Limited
- Current Assignee Address: GB Stevenage, Herts
- Agency: LeClairRyan PLLC
- Main IPC: A61K31/5383
- IPC: A61K31/5383 ; A61K31/436 ; A61K31/40 ; A61K31/4436 ; A61K31/4439 ; A61K31/444 ; A61K31/5365
Abstract:
This invention relates to new use of dual NK-1/NK-3 receptor antagonists or a pharmaceutically acceptable salt thereof in the treatment of sex-hormone dependent diseases.
Public/Granted literature
- US20160339037A1 Novel Uses Public/Granted day:2016-11-24
Information query
IPC分类:
